Trehalulose
| Product Name | Trehalulose |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-T-96124 |
| CAS No. | 51411-23-5 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 342.30 g/mol |
| Mol. For. | C12H22O11 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
Glucoerucin potassium salt | GT3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Ac4 GalNAz | GD1aCer d20:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2sph d18:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GM1aCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3sph d20:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | GM1bCer d18:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | Sucrose dilaurate | GlcCer d18:1/20:0 (GlcbCeramide) | GQ3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/12:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2sph d20:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Gluconapin | GQ3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | iGloboH | GD1bCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d20:1/18:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GD1bCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1sph d18:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Glucobrassicanapin potassium salt | GalNAcproN3 | FucGM1Cer d20:1/12:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/8:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/20:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1aCer d18:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3Galb1, 4GlcNAc | Epiprogoitrin potassium salt | FucGM1Cer d20:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/24:1 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GM2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GlcNAcb1, 3Gal | GD1bsph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Lactose PEG-NH2 | Sialyl-iGb5 | GloboH | GM3Cer d18:1/24:1 (Neu5Aca2,3Galb1,4GlcbCeramide) | Lacto-N-difucohexaose | Blood type tetrasaccharide A Type VI | GD1aCer d18:1/12:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | Gala1, 4Galb1, 4Glc | iGloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GM2sph d18:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Pk(Gala1,4Galb1,4GlcbR) | GT1cCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3Galb1, 4(Fuca1, 3)GlcNAc | GM3Cer d20:1/16:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | SSEA-4 d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GM2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | Sakuranin | LewisxCer d18:1/18:0-Biotin (Galb1,4(Fuca1,3)GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GD1aCer d18:1/18:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | LNnDFH II | GM1bCer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,4Galb1,4GlcbCeramide-Biotin) | Ac3 6AzGlcNAc | Galb1, 4GlcNAcb1, 3Galb1, 4GlcNAcb1, 3Galb1, 4GlcNAc | Glucolepidiin potassium salt | GD2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d20:1/20:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | C24:1 β-Glucosylceramide | GT1cCer d20:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2Cer d20:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Glucoiberin potassium salt | GM2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) |